July 30, 2021 - ROSEN LOGO.jpg
AMRN INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMRN
02 déc. 2021 19h45 HE | The Rosen Law Firm PA
NEW YORK, Dec. 02, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Amarin Corporation plc (NASDAQ: AMRN) between December 5,...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LONGSTANDING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMRN
29 oct. 2021 17h34 HE | The Rosen Law Firm PA
NEW YORK, Oct. 29, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Amarin...
22157.jpg
Global $650+ Billion Generic Drugs Market to 2025: Competitive Landscape, Trends, Structure, Recent Mergers and Acquisitions, Brand Name Company Involvement
31 mai 2021 06h48 HE | Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "Global Generic Drugs Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global market for generic drugs should grow...
Jubilant Pharma.jpg
Jubilant Receives Favorable Rulings from the U.S. Patent Office Invalidating Bracco Rubidium-Infusion-System Patents
17 févr. 2020 08h00 HE | Jubilant Pharma
YARDLEY, Pa., Feb. 17, 2020 (GLOBE NEWSWIRE) -- On February 7, 2020, Jubilant DraxImage Inc., and certain of its affiliates (“Jubilant”) were informed by the U.S. Patent Office that it agreed with...
SunGen Pharma.jpg
SunGen Pharma Receives Eighth ANDA Approval from US FDA
31 oct. 2019 13h51 HE | SunGen Pharma LLC
PRINCETON, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
SunGen Pharma.jpg
SunGen Pharma 制药获得美国 FDA 的第八个 ANDA 批准
31 oct. 2019 13h51 HE | SunGen Pharma LLC
新泽西州普林斯顿市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- 2019 年 10 月 31 日:  SunGen Pharma, 一家私人控股的研发,生产,和销售制剂产品的制药公司,今天宣布其已获得美国食品与药物管理局(FDA)的第八个 ANDA文号批准。 第八个ANDA的产品名为利多卡因软膏 5% (Lidocaine Ointment USP 5%),...
SunGen Pharma.jpg
SunGen Pharma 製藥獲得美國 FDA 的第八個 ANDA 批准
31 oct. 2019 13h51 HE | SunGen Pharma LLC
新澤西州普林斯頓市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, 一家私人控股的研發,生產,和銷售製劑產品的製藥公司,今天宣布其已獲得美國食品與藥物管理局(FDA)的第八個ANDA文號批准。 第八個ANDA的產品名為利多卡因軟膏 5% (Lidocaine Ointment USP 5%), 每管規格為1.5盎司(35.44克)...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic
03 janv. 2019 07h30 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
SunGen Pharma.jpg
SunGen Pharma Receives Its Second and Third ANDA Approval from US FDA
11 déc. 2018 07h30 HE | SunGen Pharma LLC
PRINCETON, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
SunGen Pharma.jpg
SunGen Pharma Receives US FDA Approval for Prednisone ANDA
10 déc. 2018 12h28 HE | SunGen Pharma LLC
PRINCETON, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...